Skip to main content

Table 2 Laboratory data

From: Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease

  Before treatment 10 weeks after treatment 20 weeks after treatment
Remission patients (n = 26)    
Haemoglobin Mean g/l (range g/l) 135 (97-164) 134 (95-154) 137 (117-162)
Mean white cell count x10/1 (range) 7.8 (1.8-15.6) 7.1 (2.4-15.8) 6.8 (0.0-12.6)
Albumin Mean g/l (range g/l) 39.4 (33.0-50.0) 39.8 (34.0-45.0) 40.3 (31.0-48.0)
CRP N 10 mg/l or over (total) 3 (23) 3 (23) 2 (22)
Responded patients (n = 8)    
Haemoglobin Mean g/l (range g/l) 135 (100-162) 127 (107-156) 130 (113-150)
Mean white cell count x10/1 (range) 12.5 (9.7-17.2) 8.9 (6.0-11.3) 8.6 (3.8-10.8)
Albumin Mean g/l (range g/l) 34.8 (29.0-41.0) 37.6 (33.0-42.0) 36.7 (32.0-39.0)
CRP N 10 mg/l or over (total) 3 (8) 2 (7) 3 (7)
Non response patients (n = 6)    
Haemoglobin Mean g/l (range g/l) 120 (82-164) 122 (93-146) 131 (112-153)
Mean white cell count x10/1 (range) 8.9 (4.8-24.3) 8.3 (5.4-19.7) 10.5 (4.6-21.6)
Albumin Mean g/l (range g/l) 39.0 (35.0-42.0) 37.3 (32.0-41.0) 37.5 (34.0-41.0)
CRP N 10 mg/l or over (total) 3 (6) 2 (6) 3 (5)
  1. Before treatment only white cell count differed significantly (p = 0.004) between the three groups (remission/response/non-responders). At 20 weeks after treatment, however, as white cell count still differed significantly between the groups (p = 0.038), so did Albumin (p = 0.038) and C-Reactive Protein (p = 0.021).